These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Syntheses and anti-HIV activities of (+/-)-norcarbovir and (+/-)-norabacavir. Huang W; Miller MJ; De Clercq E; Balzarini J Org Biomol Chem; 2007 Apr; 5(8):1164-6. PubMed ID: 17406712 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and Antiviral Evaluation of TriPPPro-AbacavirTP, TriPPPro-CarbovirTP, and Their 1',2'-cis-Disubstituted Analogues. Weising S; Sterrenberg V; Schols D; Meier C ChemMedChem; 2018 Sep; 13(17):1771-1778. PubMed ID: 29943432 [TBL] [Abstract][Full Text] [Related]
5. Application of the phosphoramidate ProTide approach to 4'-azidouridine confers sub-micromolar potency versus hepatitis C virus on an inactive nucleoside. Perrone P; Luoni GM; Kelleher MR; Daverio F; Angell A; Mulready S; Congiatu C; Rajyaguru S; Martin JA; Levêque V; Le Pogam S; Najera I; Klumpp K; Smith DB; McGuigan C J Med Chem; 2007 Apr; 50(8):1840-9. PubMed ID: 17367121 [TBL] [Abstract][Full Text] [Related]
6. Improved antiviral activity of the aryloxymethoxyalaninyl phosphoramidate (APA) prodrug of abacavir (ABC) is due to the formation of markedly increased carbovir 5'-triphosphate metabolite levels. Balzarini J; Aquaro S; Hassan-Abdallah A; Daluge SM; Perno CF; McGuigan C FEBS Lett; 2004 Aug; 573(1-3):38-44. PubMed ID: 15327972 [TBL] [Abstract][Full Text] [Related]
7. Membrane permeation characteristics of abacavir in human erythrocytes and human T-lymphoblastoid CD4+ CEM cells: comparison with (-)-carbovir. Mahony WB; Domin BA; Daluge SM; Zimmerman TP Biochem Pharmacol; 2004 Nov; 68(9):1797-805. PubMed ID: 15450945 [TBL] [Abstract][Full Text] [Related]
8. An investigation into the anti-HIV activity of 2',3'-didehydro-2',3'-dideoxyuridine (d4U) and 2',3'-dideoxyuridine (ddU) phosphoramidate 'ProTide' derivatives. Mehellou Y; Balzarini J; McGuigan C Org Biomol Chem; 2009 Jun; 7(12):2548-53. PubMed ID: 19503928 [TBL] [Abstract][Full Text] [Related]
9. First example of phosphoramidate approach applied to a 4'-substituted purine nucleoside (4'-azidoadenosine): conversion of an inactive nucleoside to a submicromolar compound versus hepatitis C virus. Perrone P; Daverio F; Valente R; Rajyaguru S; Martin JA; Lévêque V; Le Pogam S; Najera I; Klumpp K; Smith DB; McGuigan C J Med Chem; 2007 Nov; 50(22):5463-70. PubMed ID: 17914786 [TBL] [Abstract][Full Text] [Related]
11. The presence of substituents on the aryl moiety of the aryl phosphoramidate derivative of d4T enhances anti-HIV efficacy in cell culture: A structure-activity relationship. Siddiqui AQ; Ballatore C; McGuigan C; De Clercq E; Balzarini J J Med Chem; 1999 Feb; 42(3):393-9. PubMed ID: 9986709 [TBL] [Abstract][Full Text] [Related]
12. The antiviral activity, mechanism of action, clinical significance and resistance of abacavir in the treatment of pediatric AIDS. Melroy J; Nair V Curr Pharm Des; 2005; 11(29):3847-52. PubMed ID: 16305515 [TBL] [Abstract][Full Text] [Related]
13. Diastereoselective synthesis of aryloxy phosphoramidate prodrugs of 3'-deoxy-2',3'-didehydrothymidine monophosphate. Roman CA; Balzarini J; Meier C J Med Chem; 2010 Nov; 53(21):7675-81. PubMed ID: 20945915 [TBL] [Abstract][Full Text] [Related]
14. Synthesis, antiviral activity, and mechanism of drug resistance of D- and L-2',3'-didehydro-2',3'-dideoxy-2'-fluorocarbocyclic nucleosides. Wang J; Jin Y; Rapp KL; Bennett M; Schinazi RF; Chu CK J Med Chem; 2005 Jun; 48(11):3736-48. PubMed ID: 15916425 [TBL] [Abstract][Full Text] [Related]
15. Metabolism of O6-propyl and N6-propyl-carbovir in CEM cells. Parker WB; Shaddix SC; Rose LM; Pham PT; Hua M; Vince R Nucleosides Nucleotides Nucleic Acids; 2000 Apr; 19(4):795-804. PubMed ID: 10960036 [TBL] [Abstract][Full Text] [Related]
17. Aryloxy phosphoramidate triesters: a technology for delivering monophosphorylated nucleosides and sugars into cells. Mehellou Y; Balzarini J; McGuigan C ChemMedChem; 2009 Nov; 4(11):1779-91. PubMed ID: 19760699 [TBL] [Abstract][Full Text] [Related]
18. Phosphoramidate ProTides of the anticancer agent FUDR successfully deliver the preformed bioactive monophosphate in cells and confer advantage over the parent nucleoside. McGuigan C; Murziani P; Slusarczyk M; Gonczy B; Vande Voorde J; Liekens S; Balzarini J J Med Chem; 2011 Oct; 54(20):7247-58. PubMed ID: 21892829 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and conformational analysis of a locked analogue of carbovir built on a bicyclo[3.1.0]hex-2-enyl template. Choi Y; Sun G; George C; Nicklaus MC; Kelley JA; Marquez VE Nucleosides Nucleotides Nucleic Acids; 2003 Dec; 22(12):2077-91. PubMed ID: 14714758 [TBL] [Abstract][Full Text] [Related]
20. Phosphoramidate ProTides of 2'-C-methylguanosine as highly potent inhibitors of hepatitis C virus. Study of their in vitro and in vivo properties. McGuigan C; Gilles A; Madela K; Aljarah M; Holl S; Jones S; Vernachio J; Hutchins J; Ames B; Bryant KD; Gorovits E; Ganguly B; Hunley D; Hall A; Kolykhalov A; Liu Y; Muhammad J; Raja N; Walters R; Wang J; Chamberlain S; Henson G J Med Chem; 2010 Jul; 53(13):4949-57. PubMed ID: 20527890 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]